Published in PLoS One on July 07, 2014
miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1. Biosci Rep (2015) 0.92
Neuropilin-1 as Therapeutic Target for Malignant Melanoma. Front Oncol (2015) 0.83
High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis: role in TGF-β1-induced epithelia-to-mesenchymal transition. Sci Rep (2017) 0.75
Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma. Oncotarget (2016) 0.75
Anticancer effects of valproic acid on oral squamous cell carcinoma via SUMOylation in vivo and in vitro. Exp Ther Med (2016) 0.75
Axon guidance molecule semaphorin3A is a novel tumor suppressor in head and neck squamous cell carcinoma. Oncotarget (2016) 0.75
Neuropilin 1 Receptor Is Up-Regulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma. Am J Pathol (2016) 0.75
Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers. Int J Mol Sci (2017) 0.75
Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma. Oncogenesis (2017) 0.75
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 34.99
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol (2006) 23.04
Tumour stem cells and drug resistance. Nat Rev Cancer (2005) 15.21
Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell (2008) 14.80
NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer (2002) 11.39
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell (1998) 10.32
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest (2004) 5.06
Neuropilin is a semaphorin III receptor. Cell (1997) 4.88
Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell (1997) 4.77
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res (2009) 3.30
Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer (2005) 3.27
A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature (2011) 3.25
Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol (2004) 2.82
Neuropilins: structure, function and role in disease. Biochem J (2008) 2.45
The role of neuropilins in cancer. Mol Cancer Ther (2006) 2.28
Cancer stem cells in solid tumors: an overview. Semin Radiat Oncol (2009) 1.98
Neuropilins in neoplasms: expression, regulation, and function. Exp Cell Res (2006) 1.93
Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem (2003) 1.82
VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer (2000) 1.54
C terminus of RGS-GAIP-interacting protein conveys neuropilin-1-mediated signaling during angiogenesis. FASEB J (2006) 1.50
Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Cancer (2002) 1.48
Neuropilins in tumor biology. Clin Cancer Res (2009) 1.44
Epithelial-mesenchymal transition: NF-kappaB takes center stage. Cell Cycle (2004) 1.38
Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity. Oncotarget (2012) 1.37
The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett (2006) 1.30
Cancer stem cells and novel targets for antitumor strategies. Curr Pharm Des (2012) 1.24
Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics (2000) 1.21
Epithelial-mesenchymal transition in the skin. J Dermatol Sci (2010) 1.20
Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes. Cancer Res (2008) 1.19
Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. Cancer (2003) 1.16
The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit. Genes Cancer (2010) 1.14
Neuropilins: a versatile partner of extracellular molecules that regulate development and disease. Front Biosci (2008) 1.07
Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation. Biochem Biophys Res Commun (2012) 1.06
Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer. Int J Oncol (2006) 1.04
Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors. APMIS (2004) 0.96
MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. PLoS One (2014) 0.93
Epigenetic coordination of signaling pathways during the epithelial-mesenchymal transition. Epigenetics Chromatin (2013) 0.91
Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients. PLoS One (2014) 0.88
Expression of semaphorin 3A and neuropilin 1 with clinicopathological features and survival in human tongue cancer. Med Oral Patol Oral Cir Bucal (2012) 0.87
Neuropilin-1 in the immune system. Adv Exp Med Biol (2002) 0.87
Neuropilin-1 expression in squamous cell carcinoma of the oesophagus. Eur J Cardiothorac Surg (2013) 0.86